Science with health consequences

International Journal of Occupational and Environmental Health

Volumn 12, Issue 2, 2006, Pages 177-179

  Cranor, Carl F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; BENZENE; BENZIDINE DERIVATIVE; CHROMIUM; LEAD; ROFECOXIB; SODIUM CYANIDE; VINYL CHLORIDE;

CHEMICAL INDUSTRY; DRUG INDUSTRY; EDITORIAL; ENVIRONMENTAL HEALTH; ETHICS; HEALTH HAZARD; HUMAN; LAW SUIT; MEDICAL RESEARCH; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; PRIORITY JOURNAL; PUBLIC HEALTH; SCIENCE; STEM CELL; UNSPECIFIED SIDE EFFECT;

EID: 33749165895     PISSN: 10773525     EISSN: None     Source Type: Journal    
DOI: 10.1179/oeh.2006.12.2.177     Document Type: Editorial

References (27)

1. Sang-Hun C, Wade, N. Korean cloning scientist quits over the report he faked research. The New York Times, December 24, 2005. A1.
2. People v. O'Neill, Film Recovery Systems, et al., 550 N.E. 2d 1090 (1990).
3. Curfman GD, Morrissey S, Drazen JM. Expression of concern: Bombardier et al. Comparison of upper gastrointestinal toxicity of Rofecoxib and Naproxen in patients with rheumatoid arthritis. N Engl J Med. 2005;343:2813-4.
4. N Engl J Med 35326, 〈www.NEJM.org〉. December 20, 2005. Merck and Company.
5. Waldman P. Study tied pollutant to cancer; the consultants got hold of it. Wall Street Journal. December 23, 2005. 〈http://online.wsj.com/ article_print/SB113530126572230084.html〉.
6. Egilman D, Rankin Bohme S. Over a barrel: corporate corruption of science and its effects on workers and the environment. Int J Occup Environ Health. 2004;11:331-7. 〈www.ijoeh.com〉.
7. Lane, A. Polluters gain as Jersey lifts limit for toxin. Work of scientist paid by the firms viewed skeptically by other experts. The [Newark, NJ] Star-Ledger, March 7 2004.
8. Huff J, Hoel D. Perspective and overview of the concepts and value of hazard identification as the initial phase of risk assessment for cancer and human health. Scand J Work Environ Health. 1992;18:83-9.
9. Dennison R. U.S. HPV challenge and beyond. Ward, Kershaw, and Center for Progressive Regulation Environmental Law Symposium: The Data Gaps Dilemma: Why Toxic Ignorance Threatens Public Health, May 6, 2005.
10. National Research Council. Toxicity Testing: Strategies to Determine Needs and Priorities. Washington, DC: National Academy Press, 1984: 84.
11. Bailar JC, Bingham E. Personal communication, Collegium Ramazzini, 2002.
12. Gennaro V, Tomatis T. How epidemiologic studies may underestimate or fail to detect increased risks of cancer and other diseases. Int J Occup Environ Health. 2005;11:356-9.
13. Written Direct Testimony of Sander Greenland, DrPH, in Opposition to Baxter Healthcare Corporation's Petition for Declaratory Judgment. (1999, April 30) (critiquing a scientist for Baxter Health Care).
14. American Petroleum Institute. Shanghai Study: Internal Documents. 54-7.
15. Capiello D. Oil industry funding study to contradict cancer claims. Houston Chronicle, April 29, 2005, AD; A1.
16. Eysenck HJ. Were we really wrong? Am J Public Health. 1991;133:429-32 [arguing that studies must be established "beyond a reasonable doubt" before finding that cigarette smoke causes cancer].
17. Greenland S. Invited commentary: science versus public health actions: those who were wrong are still wrong. Am J Public Health. 1991;133:435-6 [critiquing the Eysenck paper].
18. Michaels D. Doubt is their product. Scientific American. 2005;96:96-101.
19. Brown & Williamson - Smoking and Health Proposal, Doc. No. 332506. 〈http://tobaccodocuments.org/bw/3 32506.html〉.
20. Brodeur P. Outrageous Misconduct. New York: Pantheon Books, 1985.
21. Markowitz G, Rosner D. Deceit and Denial: The Deadly Politics of Industrial Pollution. Berkeley, CA: University of California Press, 2002: 226-33, 300-1.
22. Michaels D, Monforton C. Manufacturing uncertainty: contested science and the protection of the public's health and environment. Am J Public Health. 2005;95;S39-S48, esp. S41, note 46 [citing internal Hill and Knowlton memos].
23. Michaels D. Waiting for the body count: corporate decision making and bladder cancer in the U.S. dye industry. Medical Anthropology Quarterly. 1988;2:215-27.
24. Rankin Bohme S, Zorabedian J, Egilman D. Maximizing profit and endangering health: corporate strategies to avoid litigation and regulation. Int J Occup Environ Health. 2005; 11:338-48.
25. Breilh J, Branco JC, Castleman BI, et al. Texaco and its consultants. Int J Occup Environ Health. 2005;11:217-20.
26. Rothman KJ, Arellano F. Elevating the level of scientific discourse [letter]. Int J Occup Environ Health. 2005;11:327-8.
27. Gitlin JN, Cook LL, Linton OW, Garrett-Mayer E. Comparison of "B" readers' interpretations of chest radiographs for asbestos related changes. Acad Radiol. 2004;11:834-56 [found highly significant differences between plaintiffs' experts' readings of chest radiographs compared with independent readers'; plaintiffs' experts' positive readings suggesting lung impairment were much more frequent than independent readers'; the differences are too substantial to be attributed to interobserver variability].